All Pharma News
price-trendAsk Us
Gilead Sciences Completes Acquisition of MiroBio

Gilead Sciences Completes Acquisition of MiroBio
BUSINESSWIRE
20 Sep 2022
Share Share
Gilead Sciences to acquire OSE portfolio company for approximately $405m

Gilead Sciences to acquire OSE portfolio company for approximately $405m
PHARMACEUTICAL MANUFACTURER
16 Aug 2022
Share Share
Gilead buys MiroBio as it takes next-gen checkpoint therapy to the clinic

Gilead buys MiroBio as it takes next-gen checkpoint therapy to the clinic
Lei Lei Wu ENDPTS
05 Aug 2022
Share Share
MiroBio Raises $97M Series B Financing to Develop Checkpoint Agonists

MiroBio Raises $97M Series B Financing to Develop Checkpoint Agonists
GLOBENEWSWIRE
29 Jun 2022
Share Share
Oxford spinout nabs almost $100M in new cash

Oxford spinout nabs almost $100M in new cash
Kyle LaHucik ENDPTS
28 Jun 2022
Share Share
MiroBio Continues Expansion of Executive Leadership Team

MiroBio Continues Expansion of Executive Leadership Team
GLOBENEWSWIRE
08 Mar 2022
Share Share
Novartis loses cell, gene leader, digital exec—Chutes & Ladders

Novartis loses cell, gene leader, digital exec—Chutes & Ladders
Kyle LaHucik FIERCEBIOTECH
24 Sep 2021
Share Share
Novartis veteran Barth takes the helm at autoimmune biotech MiroBio

Novartis veteran Barth takes the helm at autoimmune biotech MiroBio
Amirah Al Idrus FIERCEBIOTECH
21 Sep 2021
Share Share